[1]
Dr.Sreechandan Reddy and Dr.Somnath Gupta 2021. EVALUATING THE EFFICACY OF NAB-PACLITAXEL AS NEOADJUVANT THERAPY FOR HER2+ BREAST CANCER. Journal of Population Therapeutics and Clinical Pharmacology. 28, 2 (Dec. 2021), 851–856. DOI:https://doi.org/10.53555/6t7pre51.